undamentalytics Newsletter
Sign in

Clene Inc. income statement

In fiscal 2025, Clene Inc. reported revenue of $200,000, down 41.5% on the year before, operating income of −$23.1m (a -11541.5% margin) and net income of −$26.2m. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue0101000
Cost of revenue—000000
Gross profit—001000
Research and development15283227201413
General and administrative52217141398
Operating income−20−50−48−41−33−23−21
Interest expense1135433
Net interest income—−1−3————
Income before tax−19−10−30−50−39−26−40
Income tax0−000000
Net income−19−10−30−50−39−26−40
Diluted EPS−$1.10−$3.20————−$3.50
Diluted shares (average)—3m3m5m7m10m11m
EBITDA−19−49−47−39−31−22−19

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: CLDX vs CLNNCLNN vs CRVOCLNN vs IBIO

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Clene Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Clene Inc.